Zdrowie i gospodarka · 04/10/2007

FDA Proposes Changes to Electrocardiograph Electrode Device Classification

The FDA is proposing to exempt the electrocardiograph electrode device from premarket notification requirements and establish special controls to ensure its safety and effectiveness, with a draft guidance document available for public review.